Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice

Background Although glycoursodeoxycholic acid (GUDCA) has been associated with the improvement of metabolic disorders, its effect on atherosclerosis remains elusive. This study aimed to investigate the role of GUDCA in the development of atherosclerosis and its potential mechanisms. Methods and Resu...

Full description

Bibliographic Details
Main Authors: Kan Huang, Chenshu Liu, Meixiu Peng, Qiao Su, Ruiming Liu, Zeling Guo, Sifan Chen, Zilun Li, Guangqi Chang
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.019820
_version_ 1811332674337374208
author Kan Huang
Chenshu Liu
Meixiu Peng
Qiao Su
Ruiming Liu
Zeling Guo
Sifan Chen
Zilun Li
Guangqi Chang
author_facet Kan Huang
Chenshu Liu
Meixiu Peng
Qiao Su
Ruiming Liu
Zeling Guo
Sifan Chen
Zilun Li
Guangqi Chang
author_sort Kan Huang
collection DOAJ
description Background Although glycoursodeoxycholic acid (GUDCA) has been associated with the improvement of metabolic disorders, its effect on atherosclerosis remains elusive. This study aimed to investigate the role of GUDCA in the development of atherosclerosis and its potential mechanisms. Methods and Results Human THP‐1 macrophages were used to investigate the effect of GUDCA on oxidized low‐density lipoprotein–induced foam cell formation in vitro. We found that GUDCA downregulated scavenger receptor A1 mRNA expression, reduced oxidized low‐density lipoprotein uptake, and inhibited macrophage foam cell formation. In an in vivo study, apolipoprotein E–deficient mice were fed a Western diet for 10 weeks to induce atherosclerosis, and then were gavaged once daily with or without GUDCA for 18 weeks. Parameters of systemic metabolism and atherosclerosis were detected. We found that GUDCA improved cholesterol homeostasis and protected against atherosclerosis progression as evidenced by reduced plaque area along with lipid deposition, ameliorated local chronic inflammation, and elevated plaque stability. In addition, 16S rDNA sequencing showed that GUDCA administration partially normalized the Western diet–associated gut microbiota dysbiosis. Interestingly, the changes of bacterial genera (Alloprevotella, Parabacteroides, Turicibacter, and Alistipes) modulated by GUDCA were correlated with the plaque area in mice aortas. Conclusions Our study for the first time indicates that GUDCA attenuates the development of atherosclerosis, probably attributable to the inhibition of foam cell formation, maintenance of cholesterol homeostasis, and modulation of gut microbiota.
first_indexed 2024-04-13T16:40:32Z
format Article
id doaj.art-f85a71417e164a788afa5c26a1aa104b
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-13T16:40:32Z
publishDate 2021-04-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-f85a71417e164a788afa5c26a1aa104b2022-12-22T02:39:15ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-04-0110710.1161/JAHA.120.019820Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient MiceKan Huang0Chenshu Liu1Meixiu Peng2Qiao Su3Ruiming Liu4Zeling Guo5Sifan Chen6Zilun Li7Guangqi Chang8Division of Vascular Surgery First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaDivision of Vascular Surgery First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaDivision of Vascular Surgery First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaAnimal Center First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaNational‐Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaZhongshan School of Medicine Sun Yat‐sen University Guangzhou ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Medical Research Center Sun Yat‐Sen Memorial Hospital Guangzhou ChinaDivision of Vascular Surgery First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaDivision of Vascular Surgery First Affiliated Hospital, Sun Yat‐sen University Guangzhou ChinaBackground Although glycoursodeoxycholic acid (GUDCA) has been associated with the improvement of metabolic disorders, its effect on atherosclerosis remains elusive. This study aimed to investigate the role of GUDCA in the development of atherosclerosis and its potential mechanisms. Methods and Results Human THP‐1 macrophages were used to investigate the effect of GUDCA on oxidized low‐density lipoprotein–induced foam cell formation in vitro. We found that GUDCA downregulated scavenger receptor A1 mRNA expression, reduced oxidized low‐density lipoprotein uptake, and inhibited macrophage foam cell formation. In an in vivo study, apolipoprotein E–deficient mice were fed a Western diet for 10 weeks to induce atherosclerosis, and then were gavaged once daily with or without GUDCA for 18 weeks. Parameters of systemic metabolism and atherosclerosis were detected. We found that GUDCA improved cholesterol homeostasis and protected against atherosclerosis progression as evidenced by reduced plaque area along with lipid deposition, ameliorated local chronic inflammation, and elevated plaque stability. In addition, 16S rDNA sequencing showed that GUDCA administration partially normalized the Western diet–associated gut microbiota dysbiosis. Interestingly, the changes of bacterial genera (Alloprevotella, Parabacteroides, Turicibacter, and Alistipes) modulated by GUDCA were correlated with the plaque area in mice aortas. Conclusions Our study for the first time indicates that GUDCA attenuates the development of atherosclerosis, probably attributable to the inhibition of foam cell formation, maintenance of cholesterol homeostasis, and modulation of gut microbiota.https://www.ahajournals.org/doi/10.1161/JAHA.120.019820atherosclerosischolesterol homeostasisfoam cellglycoursodeoxycholic acidgut microbiota
spellingShingle Kan Huang
Chenshu Liu
Meixiu Peng
Qiao Su
Ruiming Liu
Zeling Guo
Sifan Chen
Zilun Li
Guangqi Chang
Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
atherosclerosis
cholesterol homeostasis
foam cell
glycoursodeoxycholic acid
gut microbiota
title Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice
title_full Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice
title_fullStr Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice
title_full_unstemmed Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice
title_short Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E–Deficient Mice
title_sort glycoursodeoxycholic acid ameliorates atherosclerosis and alters gut microbiota in apolipoprotein e deficient mice
topic atherosclerosis
cholesterol homeostasis
foam cell
glycoursodeoxycholic acid
gut microbiota
url https://www.ahajournals.org/doi/10.1161/JAHA.120.019820
work_keys_str_mv AT kanhuang glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT chenshuliu glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT meixiupeng glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT qiaosu glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT ruimingliu glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT zelingguo glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT sifanchen glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT zilunli glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice
AT guangqichang glycoursodeoxycholicacidamelioratesatherosclerosisandaltersgutmicrobiotainapolipoproteinedeficientmice